
Ortho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals.

Ortho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals.

Evidence does not support use of common treatments for molluscum contagiosum infections. Natural resolution may be best.

Use of the oral beta blocker propranolol for treatment of infantile hemangioma is likely behind sizable increases in resource utilization, but also decreases in the need for surgery.

Despite recommendations to limit the use of oral antibiotics, dermatologists continue to prescribe them in high numbers, according to results of a large, retrospective analysis of U.S. prescribing trends from 2004 to 2013.

A small study finds that the combination of methotrexate and azathioprine is safe and effective as maintenance treatment for patients with moderate-to-severe atopic dermatitis for up to five years.

Moisturizers were described as the “cornerstone of therapy” in atopic dermatitis in the 2014 AAD guidelines for topical therapies in atopic dermatitis, but the products differ greatly by ingredients which can improve the condition or make it worse.

Vitamin D deficiency in children is associated with being overweight while sufficiency is associated with a healthy BMI, researchers reported in December.

Dermatologist evaluations of patient acne photos submitted via smartphone compare favorably to in-person evaluations, a JAMA Dermatology study shows.

Galderma’s patient access program Galderma CareConnect recently passed the 1,000,000 filled prescriptions.

Although collectively dermatologists are doing more, each dermatologist may be doing less in the higher quintiles.

Some authors of AAD clinical practice guidelines received sizable payments from industry that were not completely disclosed, JAMA Dermatology Reports.

Humor may be subjective, but carefully and respectfully adding it to the practice can help create a positive environment for both doctor and patient.

Now that we have flipped the calendar to a new year, it’s time to say good-bye to some things we all lost in 2017.

Big cash offers not always best for the practice or patient.

A rising prevalence of skin disorders, including melanoma, will drive the need for diagnostic imaging and treatment technologies in dermatology, market analysts say.

The January issue of Dermatology Times focuses on the role of technology in clinical practice beginning with artificial intelligence for skin cancer detection and device trends in 2018. (©Elnur/Shutterstock.com)

Dermatologists should be prepared to counsel patients about PBMT home-based treatment options for hair loss, say dermatologists from the University of Minnesota who reviewed 13 FDA-approved PBMT devices. (©EvgeniyKalinovskiy/Shutterstock.com)

A conversation with ASDS president-elect Murad Alam, M.D.

Dermatologists will need to understand new device technologies and incorporate them judiciously into disease treatment where appropriate.

The FDA has proposed regulating the cosmetic industry, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums." This month Dr. Draelos examines three key questions about cosmetic safety.

Soap has probably done more to improve world health than any prescription medication, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums."

In 2018 at just five days into the New Year, a search of PubMed revealed 86 new psoriasis studies. So, who is leading the pack?

Study shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.


Dr. Derm logged into his office computer system, only to find a ransom note from a hacker, asking for money in exchange for the safe return of his patients’ records. Who are these hackers? How do they gain access? What should Dr. Derm do?

Although most malpractice cases against dermatologists are abandoned, withdrawn or dismissed, communication with patients may minimize liability.

Neural networks do pattern recognition just as a dermatologist would learn patterns and visual data. Computer accuracy rivals that of humans for classifying skin cancer. Deep neural networks and artificial intelligence may have a growing role in practice.

The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data, and there was no association between market concentration and price of the oral antibiotic. Clinician or pharmacy level interventions to choose less costly oral tetracycline-class antibiotics could result in substantial cost savings.

Dermatologists need to be aware of margin of error and related issues that can affect the results of biosimilar clinical trials, a study shows.

What exciting new devices, drugs and treatments will the New Year bring dermatologists and their patients? Physicians in the specialty and others share what they most anticipate in the coming year.